TABLE 69Resource use by HAQ band233

HAQ bandInpatient daysaJoint replacement proceduresaTotal cost (£), (IQR)
0.0–0.50.260.00121, (59–173)
0.5–1.00.130.0177, (43–109)
1.0–1.50.510.02269, (141–382)
1.5–2.00.720.03388, (206–550)
2.0–2.51.860.04909, (459–1295)
2.5–3.04.160.051945, (958–2778)
a

Uncertainty is not reported around these estimates.

From: Appendix 15, Impact of Health Assessment Questionnaire on health service costs

Cover of Etanercept, Infliximab and Adalimumab for the Treatment of Psoriatic Arthritis: A Systematic Review and Economic Evaluation
Etanercept, Infliximab and Adalimumab for the Treatment of Psoriatic Arthritis: A Systematic Review and Economic Evaluation.
Health Technology Assessment, No. 15.10.
Rodgers M, Epstein D, Bojke L, et al.
Southampton (UK): NIHR Journals Library; 2011 Feb.
© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.